1. Combined Anticancer Effect of Plasma-Activated Infusion and Salinomycin by Targeting Autophagy and Mitochondrial Morphology
    Takashi Ando et al, 2021, Frontiers in Oncology CrossRef
  2. Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy
    Jin Zhang et al, 2018, Cellular and Molecular Life Sciences CrossRef
  3. Autophagy, NAFLD and NAFLD-Related HCC
    William K. K. Wu et al, 2018, Obesity, Fatty Liver and Liver Cancer CrossRef
  4. Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway
    Liubing Hu et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  5. Levamisole enhances DR4-independent apoptosis induced by TRAIL through inhibiting the activation of JNK in lung cancer
    Xinran Qiao et al, 2020, Life Sciences CrossRef
  6. 17-Hydroxy Wortmannin Restores TRAIL's Response by Ameliorating Increased Beclin 1 Level and Autophagy Function in TRAIL-Resistant Colon Cancer Cells
    Sheng Dai et al, 2019, Molecular Cancer Therapeutics CrossRef
  7. RuvBL1 Maintains Resistance to TRAIL-Induced Apoptosis by Suppressing c-Jun/AP-1 Activity in Non-Small Cell Lung Cancer
    Hao Li et al, 2021, Frontiers in Oncology CrossRef
  8. Synergistic interaction of the cannabinoid and death receptor systems – a potential target for future cancer therapies?
    Attila Keresztes et al, 2017, FEBS Letters CrossRef
  9. The lncRNA CASC2 Modulates Hepatocellular Carcinoma Cell Sensitivity and Resistance to TRAIL Through Apoptotic and Non-Apoptotic Signaling
    Jichun Sun et al, 2022, Frontiers in Oncology CrossRef
  10. TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies
    Hassan Dianat-Moghadam et al, 2020, Pharmacological Research CrossRef
  11. The JNK Pathway in Drug Resistance
    Lanlin Hu et al, 2019, Targeting Cell Survival Pathways to Enhance Response to Chemotherapy CrossRef
  12. Autophagy inhibitors regulate TRAIL sensitivity in human malignant cells by targeting the mitochondrial network and calcium dynamics
    Asuka Onoe‑Takahashi et al, 2019, International Journal of Oncology CrossRef
  13. Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients
    Xiaoxiao Fan et al, 2020, Neoplasia CrossRef
  14. Autophagy orchestrates resistance in hepatocellular carcinoma cells
    Homeyra Seydi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  15. Cold PSM, but not TRAIL, triggers autophagic cell death: A therapeutic advantage of PSM over TRAIL
    Tomohisa Ito et al, 2018, International Journal of Oncology CrossRef
  16. ACSL5 genotype influence on fatty acid metabolism: a cellular, tissue, and whole-body study
    Abishankari Rajkumar et al, 2018, Metabolism CrossRef
  17. NanoTRAIL‐Oncology: A Strategic Approach in Cancer Research and Therapy
    Yesi Shi et al, 2018, Advanced Healthcare Materials CrossRef
  18. Elaeagnus angustifolia Plant Extract Inhibits Epithelial-Mesenchymal Transition and Induces Apoptosis via HER2 Inactivation and JNK Pathway in HER2-Positive Breast Cancer Cells
    Ayesha Jabeen et al, 2020, Molecules CrossRef